Gene Synthesis Market Analysis by Trends, Technological Advancement, Forecast till 2028
Double-stranded DNA molecules are chemically synthesised in vitro during gene synthesis. It is a biotechnology tool and has a significant impact on the field of synthetic biology. In several recombinant DNA technology sectors, such as gene therapy, vaccine development, molecular engineering, and heterologous gene expression, the technique has emerged as a key tool. It can aid in the development of new enzymes for the treatment of cancer. Additionally, it can be applied to the real-time diagnosis of viral genomes for vaccine development. Without a template DNA strand, gene synthesis can create mutant, recombinant, or wholly new DNA sequences. Additionally, in addition to DNA sequences, it can also create oligos, RNA, and chimeric DNA-RNA backbones.
![]() |
| Gene Synthesis Market |
Custom gene synthesis, which
stems from oligonucleotide synthesis technology, is the most effective way to
create PCR primers. This platform serves as the foundation for gene synthesis,
which uses proprietary technologies to link the oligos to create the whole gene
sequence. Previously, the cost of bespoke gene synthesis was about $0.69/base.
Codon bias issues during heterologous protein expression can be avoided using
the codon optimization tool of gene synthesis. By just including the codons
that the host intended for protein expression prefers in DNA sequences, protein
expression can be significantly increased.
The Gene
Synthesis Market is
being propelled forward by reasons such as growing government funding for
genomics, increased R&D in the field of genomics and next-generation
sequencing, and rising demand for personalised medicine. Personalized medicine
has grown in popularity in recent years because it aims to provide patients
with customised treatments based on the biological basis of their illnesses.
Massive amounts of health data are being generated by healthcare technologies,
genetics, connected devices, big data analytics, and artificial intelligence.
This enables medical professionals to diagnose patients more quickly and
accurately and to recommend treatments with greater knowledge.
Major Players Operating In The Gene Synthesis Market Include Atum,
ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec, GenScript
Biotech Corporation, Genewiz, Integrated DNA Technologies, Inc., OriGene
Technologies, Inc., and Thermo Fisher Scientific, Inc.
The capacity and financial
viability of healthcare systems around the world are being put unduly under
strain by factors including the ageing global population and the rise in the
prevalence of chronic diseases. Personalized medicine has the potential to
reduce total healthcare costs, enhance patient care, and raise safety margins.
At the molecular level, gene synthesis is also employed in the diagnosis of
viral and genetic diseases. There are now commercially available genetic tests
that can identify genetic variations and predict a person's response to certain
medications. As a result, the patient-centered approach and increased emphasis
on tailored treatment are both driving growth in the gene synthesis business.

Comments
Post a Comment